Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 32

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 32
---
 and technology committee. The science and technology committee assists and advises the board of directors with respect to scientific research and development matters. The science and technology committee’s responsibilities include, among other things:

| • |     | providing recommendations to the board of directors and management on the structure and optimization of our research and development portfolio; |

| • |     | providing recommendations to the board of directors and management on the path-to-clinic and path-to-market strategies for our programs; |

| • |     | providing recommendations to the board of directors and management on potential buy-side business development opportunities from a scientific, medical and regulatory perspective; |

| • |     | assisting management in screening and technically evaluating buy-side business development opportunities from a scientific, medical and regulatory perspective; and |

| • |     | supporting management in strategizing, messaging and networking with respect to sell-side business development opportunities from a scientific and technical perspective. |

**Shareholder Communications with Our Board of Directors Our board of directors has adopted a formal process by which shareholders may communicate with the board or any of its directors. Shareholders who wish to communicate with our board of directors may do so by 21

sending written communications addressed to our Secretary at Repare Therapeutics Inc., 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent, Québec, Canada H4S 1Z9, Attn: Secretary. Our Secretary will review each communication and will forward such communication to the board of directors or any of its directors to whom the communication is addressed, unless the communication contains advertisements or solicitations or is unduly hostile, threatening or similarly inappropriate, in which case the Secretary shall discard the communication.

Board and Board Member Self-Assessment

The nominating and corporate governance committee believes that a strong director assessment process and periodic board refreshment enhances the effectiveness of our board of directors and is an essential element of sound corporate governance. Director assessment is conducted on an annual basis at both the full board and individual director level, led by the direction of the nominating and corporate governance committee. The nominating and corporate governance committee oversees an annual board member self-assessment, which elicits each director’s opinions on the overall effectiveness of the board of directors and its committees, the information the board of directors receives, the conduct of board meetings, communication among directors and management, the oversight of key business risks and environmental, social and governance issues, board composition, and any other matters that any director wishes to raise. The results are summarized in an anonymous matter and reviewed by